Brigitte Alexandra Moreno Sánchez

Brigitte Alexandra Moreno Sánchez

Auto-generated profile, based on publicly available information

Brigitte Alexandra Moreno Sánchez

Centro de Salud Tipo A Montalvo

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2026 in Salud Medicina e Innovación Journal
Verified
Journal Article
Open access
PDF file
SGSilvia Carolina Villacres Gavilanes
Silvia Carolina Villacres Gavilanes
LMLissette Cristina Castillo Merino
Lissette Cristina Castillo Merino
LÁLisette Estefanía Reinoso Álvarez
Lisette Estefanía Reinoso Álvarez
BSBrigitte Alexandra Moreno Sánchez
Brigitte Alexandra Moreno Sánchez
Introduction: Fever without a source represents a frequent diagnostic challenge in pediatric emergency care, particularly in children under 5 years of age, due to the difficulty of distinguishing self-limited viral illnesses from serious bacterial infections. Clinical assessment remains fundamental; however, the incorporation of biomarkers, rapid diagnostic tests, and risk-stratification algorithms has modified the diagnostic approach to these patients. Objective: To analyze recent scientific evidence on the diagnostic criteria used in children under 5 years of age presenting with fever without a source, with emphasis on the clinical performance of biomarkers, ancillary diagnostic tests, and risk-stratification algorithms for the early identification of serious bacterial infections. Methods: A systematic literature review was conducted in accordance with PRISMA guidelines. PubMed, Scopus, SciELO, ScienceDirect, and Dialnet were searched. Studies published between 2024 and 2026, in English or Spanish, were included if they addressed fever without a source in pediatric patients under 5 years of age and evaluated diagnostic strategies, biomarkers, clinical algorithms, or ancillary diagnostic tests. Following the identification, screening, and eligibility assessment processes, 25 articles were included in the final synthesis. Results: The reviewed evidence indicates that risk-stratification algorithms, particularly PECARN and Step-by-Step, contribute to identifying patients with different probabilities of serious bacterial infection and may guide decisions regarding additional diagnostic testing and hospital management. Procalcitonin demonstrated favorable diagnostic performance compared with traditional biomarkers in the assessment of febrile infants. Likewise, rapid molecular tests may provide etiological information within a shorter timeframe, although their clinical utility should be interpreted alongside clinical assessment and the epidemiological context. Urinary tract infection was identified as one of the main bacterial infections associated with fever without a source. Conclusions: Current evidence supports an integrated approach combining clinical assessment, biomarkers, and risk-stratification algorithms to guide the diagnosis of serious bacterial infections in children with fever without a source. In Ecuador, limitations related to access to advanced biomarkers, molecular testing, and standardized clinical protocols may hinder the implementation of these strategies. Context-specific protocols and ongoing healthcare professional training are needed to promote evidence-based care and more rational antimicrobial use.